Brentuximab Vedotin With Chemotherapy for Patients With Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study-MedSci.cn

Brentuximab Vedotin With Chemotherapy for Patients With Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

[Anonymous]

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021; 19 (2): 15

科室
- - 订阅+
  - 更多科室
工具
服务